We report here the mapping of a chromosomal region responsible for strain-specific development of congenital hypothyroidism in mice heterozygous for null mutations in genes encoding Nkx2-1/Titf1 and Pax8. The two strains showing a differential predisposition to congenital hypothyroidism contain several single-nucleotide polymorphisms in this locus, one of which leads to a nonsynonymous amino acid change in a highly conserved region of Dnajc17, a member of the type III heat-shock protein-40 (Hsp40) family. We demonstrate that Dnajc17 is highly expressed in the thyroid bud and had an essential function in development, suggesting an important role of this protein in organogenesis and/or function of the thyroid gland. (Endocrinology  151: 1948 -1958, 2010) T he genetic basis of congenital hypothyroidism with thyroid dysgenesis (TD) is still elusive (1-3). Although there are data suggesting that non-Mendelian events might be responsible for most cases of the disease (4), a growing set of evidence has shown the involvement of Mendelian mechanisms in a number of cases of TD. TD has been associated with mutations in the TSHR (5), PAX8 (6 -10), FOXE1 (11-13), NKX2-1/TITF1 (14 -17) and NKX2-5 (18) genes. However, haplotype analysis allowed the exclusion of a role of either NKX2-1/TITF1, PAX8, FOXE1, or TSHR in a group of families with at least two members being affected by TD (19). In addition, TD could be a multigenic disorder. This hypothesis is consistent with the finding that there is no clear Mendelian transmission of TD in families with more than one affected member (20). Furthermore, in familial cases of TD associated with mutations in either the NKX2-1/TITF1 or PAX8 gene, the disease is characterized by incomplete penetrance and variable expressivity, thus suggesting the contribution of additional genes to the phenotype (3).
We report here the mapping of a chromosomal region responsible for strain-specific development of congenital hypothyroidism in mice heterozygous for null mutations in genes encoding Nkx2-1/Titf1 and Pax8. The two strains showing a differential predisposition to congenital hypothyroidism contain several single-nucleotide polymorphisms in this locus, one of which leads to a nonsynonymous amino acid change in a highly conserved region of Dnajc17, a member of the type III heat-shock protein-40 (Hsp40) family. We demonstrate that Dnajc17 is highly expressed in the thyroid bud and had an essential function in development, suggesting an important role of this protein in organogenesis and/or function of the thyroid gland. T he genetic basis of congenital hypothyroidism with thyroid dysgenesis (TD) is still elusive (1) (2) (3) . Although there are data suggesting that non-Mendelian events might be responsible for most cases of the disease (4), a growing set of evidence has shown the involvement of Mendelian mechanisms in a number of cases of TD. TD has been associated with mutations in the TSHR (5), PAX8 (6 -10), FOXE1 (11) (12) (13) , NKX2-1/TITF1 (14 -17) and NKX2-5 (18) genes. However, haplotype analysis allowed the exclusion of a role of either NKX2-1/TITF1, PAX8, FOXE1, or TSHR in a group of families with at least two members being affected by TD (19) . In addition, TD could be a multigenic disorder. This hypothesis is consistent with the finding that there is no clear Mendelian transmission of TD in families with more than one affected member (20) . Furthermore, in familial cases of TD associated with mutations in either the NKX2-1/TITF1 or PAX8 gene, the disease is characterized by incomplete penetrance and variable expressivity, thus suggesting the contribution of additional genes to the phenotype (3) .
The study of multigenic diseases in humans is difficult. Studies on mouse models indicate that the pool of genes, mostly transcription or growth factors, involved in thyroid development is rather large, and defects in these genes or in their yet unidentified targets could be relevant for the pathogenesis of TD in humans (3) . Genetically modified mice are becoming a valuable tool for the study of complex diseases. Novel strains with complex phenotypes due to polygenic defects have been generated by crossing mice carrying different mutations (21) (22) (23) (24) . Furthermore, the introgression of the same mutation in different genetic backgrounds has allowed the identification of modifier genes that protect or predispose mice to a number of diseases (25) .
Previously, we reported the generation of a polygenic mouse model for hypothyroidism (26) . Although neither Pax8 nor Nkx2-1/Titf1 heterozygous null mice show overt thyroid defects, the combination of two heterozygous null mutations, in Nkx2-1/Titf1 and Pax8, results in a severe hypothyroidism characterized by thyroid hypoplasia and increased incidence of thyroid hemiagenesis. This model has been named DHTP, for double heterozygous for Titf1 and Pax8. Interestingly, the severe hypothyroidism is present only in the C57BL6/J (B6) genetic background, whereas it is completely absent in both 129/ SvPasCrl (Sv) and DHTP/B6-Sv F1 hybrids. These data suggest that homozygosity for B6-specific alleles, in the presence of null mutations in both Nkx2-1/Titf1 and Pax8, is involved in the emergence of TD.
In the present study, we first show that the B6-specific TD phenotype of DHTP mice is associated with a reduced activation of a transgenic thyroglobulin (Tg) promoter, thus indicating that the modifier is acting on a transcriptional mechanism. To map modifier genes responsible for the B6-specific phenotype, we carried out a genetic linkage analysis in a DHTP backcross population. This analysis identified two potential loci linked to the hypothyroid phenotype, with one of them having the major effect. We have thus focused on this locus mapping on chromosome 2, which we have designated hypothyroidism-related chromosome 2 (HTRC2). On the basis of a single-nucleotide polymorphism (SNP) that causes a non synonymous amino acid change in a highly conserved protein domain between B6 and Sv strains, we identified Dnajc17, encoding for a member of the type III heat-shock protein-40 (Hsp40) family, as a candidate modifier gene for hypothyroidism. Consistent with this hypothesis is the high expression of Dnajc17 in the thyroid, its essential role in mouse embryo development and its capacity to modify the expression of the Tg promoter in transient transfection experiments.
Materials and Methods

Mice and breeding
Animals were kept in an animal house under controlled conditions of temperature, humidity, and lighting and were supplied with standard food and water ad libitum. All animal experimentation respected regulations and guidelines of Italy and the European Union and was approved by the local ethical committee.
Wild-type B6 and Sv mice were purchased from Charles River Laboratories (Calco, LC, Italy). DHTP mice have been described previously (26) . DHTP mice were backcrossed (at least for 15 generations) on B6 background to generate congenic DHTP/B6 mice. DHTP/B6 and Sv wild-type mice were mated to produce F1 hybrid DHTP/B6-Sv mice. These mice were backcrossed with B6 mice to produce backcross mice (DHTP/bc).
TgCRE transgenic mice (27) were obtained from Prof. G. Schutz (DKFZ, Heidelberg, Germany).
Dnajc17 knockout mice were generated using an embryonic stem cell clone (BayGenomics, San Francisco, CA) in which an allele of Dnajc17 had been disrupted by inserting a betageo cassette in the first intron. The clone was injected into B6 blastocysts, and chimeric mice were bred with B6 mice for germline transmission of the modified allele. The heterozygous Dnajc17 ϩ/Ϫ mice were backcrossed with B6 mice.
Genotypes of mutant mice were determined by PCR using genomic DNA isolated from the tail tips or from yolk sacs. DHTP mice were genotyped as described (26) . TgCRE transgenic mice were identified using the primers 5Ј-AGTCCCTCACATCCT-CAGGTT-3Ј and 5Ј-ATGCCAACCTCACATTTCTTG-3Ј, which amplify a 450-bp product. To genotype Dnajc17 mutants, the primers used for the amplification were the following: 5Ј-AGTCAGACGAGAATCGGAAGGC-3Ј (located in the intron I of Dnajc17 gene), 5Ј-AGGGGCTGAGGGGAGGAGTT-3Ј (located in the intron I of Dnajc17 gene), and 5Ј-CGTGTCCTACAA-CACACACTCC-3Ј (located in the gene-trap vector). PCR products were 617 bp for the wild-type allele and 376 bp for the mutated allele.
TSH measurements
TSH serum levels were measured as described previously (26) .
Immunohistochemistry
Histological sections and staining procedures were carried out as described previously (26) . A specific antibody against Dnajc17 was generated using a peptide corresponding to amino acids 100-181, as a unique antigen of Dnajc17, not shared from other proteins of the DnaJ family. The peptide preparation and the purification of the antibody were performed as described (28) . The affinity-purified antibody recognized a band at the expected apparent molecular mass of Dnajc17 (34 kDa) in either FRTL5 or HeLa cell extracts. This band appears to be specific because its signal intensity was increased in protein extracts of cells transfected with an expression vector encoding for the complete Dnajc17 coding sequence under the control of the elongation factor-1 (EF-1) promoter.
Histological sections were examined with an AXIOPLAN 2 microscope equipped with Axiocam digital camera (Zeiss, Oberkochen, Germany). Images were processed using Axion Vision software and edited with adobe Photoshop software.
Quantitative real-time PCR
Total RNA extraction and cDNA synthesis were performed as described (26) . Quantification of mRNA were performed in triplicate with an ABIPrism 7300 RT-PCR system (Applied Biosystems, Foster City, CA) using SYBR green as detector dye. Specific primer sets for each gene were designed using the program Primer Express (Applied Biosystems). The sequences of the primers used in the reactions were as follows: Nkx2-1/Titf1, 5Ј-TTACCAGGACACCATGCGG-3Ј and 5Ј-TGCCACTCA-TATTCATGCCG-3Ј; Pax8, 5Ј-GCCATGGCTGTGTAAG-CAAGA-3Ј and 5Ј-GCTTGGAGCCCCCTATCACT-3Ј; CRE, 5Ј-CCAGCCAGCTATCAACTCGC-3Ј and 5Ј-CCAGGCCAGG-TATCTCTGACC-3Ј; and Dnajc17, 5Ј-CCAAGGTGGCTACTC-CAGAGAT-3Ј and 5Ј-ACTCCACTATGGCATTGCCTG-3Ј.
The sequences of the primers for Tg and Abelson were previously described (26) . For each sample, the expression of the genes of interest was normalized for the expression of the Abelson gene measured under the same condition. The data obtained represent the mean of three independent samples, each composed of the thyroids dissected from four embryos or adult mice.
Association and linkage analysis
Genome-wide genotyping was carried out in DNA pools prepared from hypothyroid (52 animal) and euthyroid (91 animals) DHTP/bc mice. Fifty nanograms of DNA from each mouse was used to prepare the pools. SNPs were selected from public databases (www.ensembl.org, http://mousesnp.roche.com/; http:// www.well.ox.ac.uk/resources.shtml; and http://www.ncbi.nlm. nih.gov/) based on their chromosomal positions and strain distribution information. All genotypes were determined by pyrosequencing analysis on PSQ 96MA system (Biotage AB, Uppsala, Sweden). Differences in allelic frequencies between hypothyroid and euthyroid pools were scored, and the statistical significance was calculated using Fisher's exact test and plotted as ϪlogP over physical distance of the SNPs.
Individual mice were genotyped for 24 SNPs located on chromosomes 2 and 5. Recombinational maps were established by multipoint analysis of the data, using the MAPMAKER/EXP 3.0 program (29) . Genetic distances were computed using Haldane's mapping function. Linkage analysis was performed using R/qtl software (30) as reported (31) . The scanone function of R/qtl was used to define LOD score for single loci. Multipoint genotype probabilities were first calculated using the calc.genoprob function in R/qtl. The genotype probabilities were calculated at 2-cM intervals for the maximum distance between positions. Significance thresholds of single-locus genome scans (␣ ϭ 0.05; ␣ ϭ 0.1) were generated through permutation tests (10,000 permutations) as described (31) . The binary (hypothyroid vs. euthyroid mice) phenotype was analyzed using a model for binary trait according to the maximum likelihood method (32) . The search for quantitative trait loci (QTL) linked to the TSH levels of the mice was carried out using the nonparametric model (33) because this trait showed a nonnormal distribution. One-way ANOVA procedures were used to analyze the relevance of the association between TSH levels and genetic markers. Because TSH levels do not have a normal distribution, we replaced the data with their ranks, and the transformed values were analyzed by ANOVA (34) .
Western blot analyses
Thyroid glands were homogenized in lysis buffer [50 mM TrisHCl (pH 8.0), 150 mM NaCl, 5 mM MgCl 2 , 1% Triton X-100, 0.5% sodium deoxycholate, and 0.1% sodium dodecyl sulfate] supplemented with 0.5 mM phenylmethylsulfonyl fluoride and protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Cell fractionation into cytoplasmic and nuclear fractions was prepared as described (35) . Total protein or fractionated cellular extracts were separated by a gradient 4 -12% SDS-PAGE and transferred to an Immobilon membrane (Millipore, Billerica, MA). Immunodetection was performed by using rabbit polyclonal antibodies against Dnajc17, Nkx2-1/Titf1(36), and antitubulin and antiactin (both from Santa Cruz Biotechnology Inc., Santa Cruz, CA) along with an enhanced chemiluminescence detection method (Bio-Rad, Hercules, CA).
Cell culture, plasmids, and luciferase assays
HeLa cells were grown in DMEM (Euroclone, Milan, Italy) supplemented with 10% fetal calf serum (Hyclone, Logan, UT).
The expression vectors Dnajc17 B6 and Dnajc17 Sv were generated by cloning the sequence encoding the full-length cDNA of DNAjc17 from B6 and Sv strain, respectively in the EcoRI site of pCEFL plasmid vector, which directs synthesis from the EF-1 promoter. The reporter gene TgLuc and the expression vectors for Nkx2-1/Titf1 (37) and Pax8 (38) have been previously described.
Transient transfection experiments were done in triplicate and carried out as described (35) .
Results
The hypothyroid phenotype of DHTP/B6 mice is associated with a reduced Tg gene transcription
We have previously demonstrated that DHTP/B6 thyroids show reduced levels of Tg mRNA. To test whether such a reduction is due to impaired Tg gene transcription, we used the genetically modified mouse strain TgCRE (27) , which harbors a transgene containing a 20-kb DNA sequence upstream of the translation start site of the Tg gene fused to CRE-ER recombinase cistron. We first backcrossed TgCRE mice on B6 strain background for seven generations to obtain an almost congenic strain (TgCRE/ B6). These mice were then crossed with DHTP/B6 to generate triple-mutant mice, TgCRE-DHTP. As expected, these mice present high serum TSH levels due to the DHTP genotype. Fetal thyroids were dissected from both embryonic d 18 (E18) TgCRE-DHTP and control TgCRE/B6 embryos, and mRNA levels of Tg and CRE were quantified (Fig. 1A) , demonstrating that the levels of both Tg and CRE mRNAs are reduced in DHTP mice compared with controls. These data show that the TgCRE transgene is down-regulated to the same extent as the endogenous Tg gene, strongly suggesting that such down-regulation is the consequence of reduced transcriptional activity of the Tg regulatory region common to both genes. We conclude that in the B6 genetic background, the reduced dosage of Nkx2-1/Titf1 and Pax8, associated with specific B6 alleles, is not capable of sustaining a sufficient level of Tg gene transcription. Thus, the genetic modifier that differs between Sv and B6 mice must be able to either sustain (Sv alleles) or weaken (B6 alleles) Nkx2-1/Titf1 and Pax8-dependent transcription.
B6 and Sv129 thyroids have similar levels of Nkx2-1/Titf1 and Pax8
Because the reduced expression of Tg is a feature of DHTP in B6 and not in B6-Sv F1 hybrid genetic back-ground (26), we asked whether the strain dependence of this phenotype could be explained by differential expression of Nkx2-1/Titf1, Pax8, or Tg genes between B6 and B6-Sv F1 hybrid mice. We measured levels of mRNAs for Nkx2-1/Titf1, Pax8, and Tg by RT-PCR in both fetal (Fig.  1B) and adult wild-type thyroid (Fig. 1C) , but no significant difference in the expression of these genes was found between the two strains. Thus, the difference in susceptibility to the development of hypothyroidism between B6 and B6-Sv F1 hybrid is not related to significant differences in the level of expression of these genes.
Mapping of the chromosomal region responsible for differential susceptibility to hypothyroidism of DHTP mice
To map the genetic loci responsible for the differences in the phenotype between the B6 and the Sv genetic DHTP mice, we followed a strategy based on positional cloning.
Hypothyroid DHTP/B6 mice were mated with Sv wildtype mice to create euthyroid F1 DHTP in a B6-Sv hybrid background. These mice were backcrossed with wild-type B6 mice to yield a progeny, herein referred to as DHTP/bc, that contains a mixture of hypothyroid and euthyroid mice, depending on whether they inherit the appropriate B6 or Sv 129 allele from the hybrid parent (26) . Genetic mapping and phenotyping by measuring TSH levels was performed with the aim of identifying the inherited B6 segment that correlates with the hypothyroid phenotype. To this aim, we selected a cohort of 143 DHTP/bc mice in which the TSH serum levels were measured at d 30. TSH levels appeared elevated (mean value, 27.3 Ϯ 11.6 ng/ml) in 52 DHTP mice (herein referred to as HypoDHTP/bc) whereas 91 mice (referred to as EuDHTP/bc) displayed normal TSH levels (mean value, 4.5 Ϯ 2.0 ng/ml).
In a preliminary genome-wide association study, equal amounts of genomic DNAs from either hypothyroid or euthyroid DHTP/bc mice were pooled. The two pooled samples were genotyped by pyrosequencing for a set of 238 SNPs, polymorphic between B6 and Sv strains, spanning the whole genome and spaced at an interval of 10 -25 Mb on each chromosome.
As Fig. 2A shows, the hypothyroidism trait is in strong association (ϪlogP ϭ 8.0) with a region of the chromosome 2 defined by SNPs rs13476660 and rs13476825. We found another significant association on chromosome 5 with a peak region (ϪlogP ϭ 3.2) located between markers rs6281932 and rs3023045.
These regions were further investigated with genetic linkage analysis, carried out on individual DNA samples from the cohorts described above. The strength of the association between each marker and phenotype was calculated and expressed as LOD score. We first analyzed the binary (hypothyroid vs. euthyroid mice) phenotype (Fig. 2B) ; we found a linkage peak from 114 -121 Mb with LOD score of 12.20 at rs13476722 on chromosome 2 and another peak from 29 -93 Mb with LOD score 3.42 at rs13478217 on chromosome 5. Then we analyzed the TSH levels of the mice as a continuous quantitative trait; because this trait showed a nonnormal distribution, we used a nonparametric model (33) . As Fig. 2C shows, rs13476722 on chromosome 2 has significant LOD score (8.7), whereas the LOD score value for rs13478217 on chromosome 5 is below the significant threshold of ␣ ϭ 0.05, but it is above the threshold of ␣ ϭ 0.1.
Taken together, our analyses revealed a QTL (HTRC2) with a peak at rs13476722 strongly associated with the hypothyroid phenotype and suggested a possible association of the phenotype with a large region on chromosome 5 around rs13478217.
To assess the relevance attributable to these loci controlling the phenotype, we estimated the proportion of the total variability explained by the association between the marker and the TSH levels. The identified loci linked with rs13476722 and rs13478217 SNPs appeared to be strongly associated with the hypothyroid phenotype because they explain, respectively, about 28 and 4% of the variance of TSH levels in the backcross population (Table  1) . Although loci at rs13476722 and rs13478217 markers have a large size effect in modulating the phenotype, other genes might be involved. Indeed only 70% (36 of 52) of HypoDHTP/bc mice are homozygous for B6 alleles at both rs13476722 and rs13478217; on the other hand, a number of EuDHTP/bc (10 of 91) carry the susceptible genotype. We suggest that the susceptibility to hypothyroidism of DHTP mice in B6 mice depends on a mixture of high-and low-penetrance modifiers, with a major QTL located on chromosome 2, a minor one mapping on chromosome 5, and additional low-penetrance putative loci whose location and number could not be determined in this study.
Identification of candidate modifier genes in HTRC2
The difference in hypothyroidism susceptibility between B6 and Sv mice could be due to a difference in the functional properties of gene products and/or in the expression level of genes mapping in the chromosomal regions that we have identified. We decided to focus our attention only on HTRC2, given its high LOD score. A list of candidate genes in HTRC2 was obtained from complementary information from the mouse genome sequence and the SNP database. The list was filtered to keep only the SNPs polymorphic between B6 and Sv strains. Additional filtering was performed choosing SNPs that appeared only in genes having functional annotation in the Gene Ontology database and expressed in the thyroid (26) . We selected SNPs that met the criteria, such as those present in the coding sequence, the 3Ј-untranslated region, introns, and untranscribed regions up to 10 kb upstream of initiation of transcription or 10 kb downstream of the poly A signal of the gene itself. In this way, as shown in Table 2 , we obtained a list of 175 SNPs associated with eight genes. Six genes contain SNPs in noncoding regions. These polymorphisms could cause a different expression of some of these genes between mouse strain B6 and Sv. However, the analysis of Affymetrix microarray data comparing the global transcriptome of thyroids dissected from E18.5 B6 and B6-Sv hybrid mice did not show significant differences in the expression of these genes (data not shown). Then we hypothesized that the strain dependence of the hypothyroid phenotype could be due to structural differences between B6 and Sv mice in the products of genes mapping in the HTRC2 QTL. Two genes, calpain 3, a cysteine protease (39), and Dnajc17, a member of the type III Hsp40 family (40) , showed SNPs in the coding region. We con- 
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The indicated SNPs denote the marker closest to the peak: rs13476722 B6 and rs13478217 B6 , donor strain B6. F statistics are based on sum of squares; P values are based on F distribution with 142 degrees of freedom. R adj 2 indicates the percentage of the phenotypic variation of the trait that can be explained by the locus (or loci). Odds ratio (OR) is the ratio between the odds of hypothyroidism in DHTP mice homozygous for the B6 allele of the indicated SNP and the odds of hypothyroidism in mice heterozygous (B6/Sv) for the same SNP. a Probability of association between the indicated SNP and the phenotype. b The 95% confidence interval (CI) for the indicated odds ratio.
firmed these SNPs by performing nucleotide sequence analysis on PCR-amplified genomic DNA from B6 and Sv mice (data not shown). Polymorphism in calpain 3 at position 43 of the putative protein, changed a glutamine in B6 for an arginine in Sv mice. However, the relevance of this change is questionable, because this amino acid is not conserved among different mouse strains and other organisms as well (data not shown). The absence of expression of the gene encoding calpain 3 in gene expression profiles carried out on RNA extracted from E10.5 thyroid buds (data not shown) was an additional criterion to exclude calpain 3 from further studies. A more interesting scenario was observed for Dnajc17. The B6 allele encodes for a protein containing a phenylalanine residue at position 273, whereas Sv mice contain a tyrosine in that position. Interestingly, comparing the sequences of Dnajc17 among different mouse strains, we found that all these strains but B6 have Tyr at position 273; in addition, Tyr 273 was also found in all species examined (Table 3) . These data suggest Dnajc17 as a good candidate gene involved in the generation of the hypothyroidism trait in DHTP/B6 mice and was further strengthened by the expression pattern of the gene encoding Dnajc17 (see below).
Expression and function in vivo of Dnajc17
We developed a highly specific anti-Dnajc17 polyclonal antibody directed against a peptide not shared by other proteins of the DnaJ family, and we used this antibody to investigate the pattern of Dnajc17 protein expression in the mouse embryo. As Fig. 3 , A and B, shows, at E10.5, Dnajc17 protein is present in the developing thyroid. RT-PCR (Fig. 4A) and Western blot analysis (Fig.  4B) confirmed that Dnajc17 is present in both fetal and adult thyroid. In addition, the abundance of both Dnajc17 mRNA and protein is comparable in B6 and B6-Sv hybrid thyroids.
Because different members of the DnaJ protein family have been found in the cytosol, the nucleus, endosomes, and/or mitochondria, we studied the intracellular localization of Dnajc17 in rat FRTL-5 thyroid cells. Cell extracts were fractionated into nuclear and cytoplasmic fractions and subjected to Western blot analysis. Dnajc17 was recovered from both fractions, albeit in higher proportion in the nucleus (Fig. 4C) . The findings that Dnajc17 is expressed in thyroid and it is localized in the nucleus are consistent with a role of this protein in modulating the transcription of some thyroid-specific genes.
To study the in vivo role of this protein, we generated a Dnajc17-null mouse. An embryonic stem cell clone, in which an allele of Dnajc17 had been disrupted (Fig. 5A) , was injected into blastocysts to obtain chimeric mice. Male chimeras were mated with B6 females to generate Dnajc17 ϩ/Ϫ mice (Fig. 5B) . The Dnajc17 ϩ/Ϫ mice appeared normal. TSH serum levels were measured in 1-month-old Dnajc17 ϩ/Ϫ mice to test for thyroid function. TSH levels in Dnajc17 ϩ/Ϫ mice (mean value, 0.5 Ϯ 0.4 ng/ml; n ϭ 36) resulted comparable to those of wildtype (mean value, 0.8 Ϯ 0.6 ng/ml; n ϭ 17). Dnajc17
were interbred to generate Dnajc17 Ϫ/Ϫ mice. Dnajc17 Ϫ/Ϫ pups were never observed postnatally, indicating that the Dnajc17 null mutation is recessive embryonic lethal. To characterize the lethal phenotype, embryos from heterozygote intercrosses were genotyped at different days of gestation. We find Dnajc17 Ϫ/Ϫ two-cell embryos (Fig.   5C ), but no homozygous embryos were recovered after the morula stage. These findings indicate that Dnajc17
embryos were developmentally arrested before implantation and indicate an essential role of this gene in early mouse development.
Dnajc17 affects Tg transcription
It was previously reported that in transient transfection assays in HeLa cells, Nkx2-1/Titf1 efficiently activates the transcription from a reporter construct (TgLuc) in which the Tg minimal promoter directs the expression of the luciferase gene (37) . To investigate whether Dnajc17 might interfere with the Tg promoter activation, the expression vector encoding for either B6-specific Dnajc17 (Dnajc17 B6 ) or Sv-specific Dnajc17 (Dnajc17 Sv ) was cotransfected in HeLa cells together with the reporter TgLuc and the expression vector for Nkx2-1/Titf1. As shown in Fig. 5D , the expression of both Dnajc17 B6 and Dnajc17 Sv has no effect on the basal activity of Tg promoter, but it does modulate the Nkx2-1/Titf1-driven Tg promoter activity. Interestingly, Dnajc17
B6 induces a stronger down-regulation (P ϭ 0.01) than Dnajc17
Sv . Similar experiments carried out with a Pax8 expression vector resulted in no significant effects by either isoforms of Dnajc17 on this transcription factor (Fig. 5D ). These data demonstrate that the ability of Dnajc17 to interfere with Tg transcription can be significantly modified by the replacement of Tyr 273 by a phenylalanine residue.
Discussion
We report in this study the mapping of two genetic loci responsible for congenital hypothyroidism in a mouse model that suggests a multigenic origin of this frequent endocrinopathy.
Congenital hypothyroidism in humans is a complex disease, heterogeneous with respect to etiology (3) . Several mouse models carrying loss-of-function mutations in thyroid-specific genes have been generated, providing some similarities with the human situation. Recently, we have described a polygenic animal model of congenital hypothyroidism which fulfills all essential criteria of this disease in humans: elevated TSH, reduced thyroid hormones, decreased body weight accompanied by thyroid hypoplasia, and increased incidence of thyroid hemiagenesis (26) . The model, characterized by heterozygous null mutations in the genes encoding the transcription factors Nkx2-1/Titf1 and Pax8, has been named DHTP, for double heterozy- antibody (magnification, ϫ50) . B and D, Higher magnification (ϫ200) of the boxed areas in A and C, respectively. The expression of Nkx2-1/Titf1 is used as a molecular marker to identify the thyroid bud. Dnajc17 has a robust expression in developing thyroid. These data are representative of three independent experiments. gous for Titf1 and Pax8. Interestingly, the hypothyroid phenotype is present only in the B6 mice, whereas it is completely absent in both Sv and DHTP/B6-Sv F1 hybrid mice.
Using both association studies and linkage analysis, we identified two potential loci linked to the phenotype: one around rs13476722 on chromosome 2 and the other around rs13478217 on chromosome 5, both displaying a peak above the threshold value. Linkage analysis revealed that rs13476722 alone accounts for up to 28% of the phenotypic variation of the hypothyroidism trait.
The haplotype analysis of the backcross mice indicated that only 70% of hypothyroid mice are homozygous for B6 alleles at both rs13476722 and rs13478217 loci (rs13476722
). The incomplete penetrance observed in rs13476722
, rs13478217
B6/B6 mice reveals a rather complex scenario and may suggest that other additional genetic elements might control the phenotype as either single or interacting loci (41) . Our genetic analysis suggested that a novel hypothyroidism-related QTL (HTRC2) maps on chromosome 2 from 112-121 Mb, around the rs13476722 locus. To our knowledge, no previous reports have shown the presence of QTL linked to hypothyroidism on this chromosomal region in mice. To identify candidate causal genes within the HTRC2 QTL region, we examined the list of genes expressed in the thyroid that we obtained using the Affymetrix microarray (26) . Many genes map in this region, but none of these is already known to be relevant for normal or abnormal development of the thyroid in mice. Duox1 and Duox2, two genes required for thyroid hormonogenesis, are localized on chromosome 2 but outside this interval (42) .
Screening for SNPs into HTRC2 for genes expressed in the thyroid identified a number of genes containing SNPs either in noncoding regions or in the coding sequences, the latter leading to either synonymous or nonsynonymous mutations. It has been reported that genetic defects that underlie susceptibility to complex traits may be due to variations, in sequence, either in regions coding for amino acids apparently not relevant for the function of a protein or in those of noncoding regions (43) . Hence, in theory, each of the allelic variants that we found might be responsible for the observed phenotype. We decided to search first for SNPs leading to nonsynonymous changes in the corresponding protein product, and we identified two genes matching this criterion, Calpain 3 and Dnajc17. The cysteine protease calpain 3 (39) has a glutamine residue at position 43 in the B6 strain but an arginine in the same position in Sv mice. This is a rather conservative missense mutation according to Grantham's classification (44) . No thyroid defects have been reported in either calpain 3-null mice or in humans carrying mutations in the calpain 3 gene. In addition, we detected no expression of the gene encoding calpain 3 in gene expression profiles from E10.5 thyroids (data not shown). For these reasons, we excluded calpain 3 from further studies.
Dnajc17, which encodes for a type III member of the group of Hsp40 (40), could instead be recognized as a modifier of the thyroid phenotype in DHTP mice.
Indeed, Dnajc17 presents a phenylalanine residue at position 273 in the B6 mice, but it shows a tyrosine at the same position in all other mouse strains. Even though the phenylalanine-tyrosine change is a conservative missense mutation (44) , tyrosine 273 is conserved in Dnajc17 ortholog genes throughout the evolution from metazoans. It is worth noting that in humans, disease-associated mutations occur often at sites that are conserved in evolution (45) . An analysis of structure-activity relationship of Dnajc17 has not yet been reported. NCBI's Conserved Domain Database, queried for conserved domains in Dnajc17, identifies, aside from the J domain, an RNA recognition motif located between amino acids 190 and 247. In addition, analysis performed with NetPhos 2.0 software (46) predicts that tyrosine 273 is very likely to be phosphorylated, suggesting that the absence of this posttranslational modification could be responsible for an impaired function of the protein. Furthermore, Dnajc17 is expressed from the early stage of embryonic life in the developing thyroid and remains expressed in the adult thyroid as well as in differentiated thyroid follicular cells in culture.
An additional aspect that support the candidacy of Dnajc17 as a modifier gene of the DHTP phenotype is the observation that the hypothyroid phenotype in our model is associated with an impaired transcription of the Tg gene, a well known target of Nkx2-1/Titf1 and Pax8. Consistent with this are the data indicating that Dnaj proteins interact, via a highly conserved domain (J domain), with Hsp70 chaperone proteins and regulate the activity of these chaperones (40) . It has been reported that chaperone proteins can control the disassembly of transcriptional complexes (47) and can act as regulators in gene expression processes in Drosophila melanogaster (48) as well as in mammalian cells (49) . Our data showing that Dnajc17 has a nuclear localization is also consistent with the hypothesis that it could be involved in the regulation of the transcriptional activity of Nkx2-1/Titf1 and/or Pax8.
Taken together, these observations indicate that Dnajc17 satisfies many of the criteria for QTL gene discovery as proposed by the Complex Trait Consortium (50) .
Because the specific role of Dnajc17 is still unknown, we generated a novel mouse strain carrying a loss-offunction Dnajc17 allele. Mice heterozygous for the null Dnajc17 show no elevation of circulating TSH levels, suggesting the absence of significant thyroid defects. However Dnajc17-null mice die between the morula and blastocyst stages. These findings demonstrate that this gene could be involved also in the early development of the mouse embryo. Along these lines, it is of interest that in Ciona intestinalis embryos, the knockdown of Ci-FLJ10634, the Ciona ortholog of mammalian Dnajc17, results in the suppression of endoderm formation (51) .
The early lethal phenotype of the Dnajc17-null embryos prevents us from addressing the specific role of Dnajc17 in the thyroid gland. However, in a heterologous cellular system, we demonstrated not only that Dnajc17 is able to interfere with Tg transcription but also that this activity is sensitive to the replacement of tyrosine by a phenylalanine residue at position 273. This result, albeit obtained in an artificial system, suggests that Dnajc17 has the potential to affect transcription of thyroid-specific genes via an interference on Nkx2-1/Titf1 and thus is in full agreement with its suggested role as modifier of the DHTP phenotype and, more in general, as one of the genes involved in the multigenic origin of thyroid defects. The creation of an animal model with a thyroid-specific conditional inactivation of Dnajc17 will offer us a tool for the in vivo study of the involvement of Dnajc17 in thyroid gland development and physiology. These experiments are in progress.
In conclusion, the data presented provide information on the chromosomal localization of novel loci involved in hypothyroidism and suggest the syntenic regions of the human genome that could be investigated in human populations. In addition, we found that only B6 mice, among the other mouse strains, carry a mutated allele of Dnajc17 in a residue highly conserved in evolution. Because Hsp70 proteins, the partners of Dnaj, are involved in a number of biological processes, disturbances in Hsp40-Hsp70 interactions could have pleiotropic effects. Thus, minor genetic defects could be more evident on the genetic background of B6 than on that of Sv. Indeed, the frequency of aortic valve stenosis in Nkx2.5 heterozygous mice (52), the penetrance of cardiovascular and thymic defects in Df1/ ϩ mice (24) , and hyperinsulinemia in double heterozygous for insulin receptor and insulin receptor-associated protein (21) are more marked in B6 mice compared with mice carrying the same mutations on Sv background. It is thus possible that we have discovered a general modifier in B6 strains that is, at least in part, responsible for the greater sensitivity of these mice to reduced activity of regulatory molecules.
